Shin-ichi Inoue - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Shin-ichi Inoue

Showing results (91-100 of 93) with videos related to

Pageof 10

Sort By:

You have reached the last page of results.This site can display upto 93 results.

Ebiomedicine|April 17, 2026

An observational study to test the potency of GLP-grade phenol-free lyophilised leishmanin antigen formulationThalia Pacheco-Fernandez, Laura Klenow, Shin-Ichi Inoue, et al.

Nature Communications|April 2, 2021

Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humansAngelica Gualtieri, Nikolina Kyprianou, Louise C Gregory, et al.

American Journal of Medical Genetics. Part A|December 12, 2019

The sixth international RASopathies symposium: Precision medicine-From promise to practiceKaren W Gripp, Lisa Schill, Lisa Schoyer, et al.

Pageof 10

Search research articles

Showing results (91-100 of 93) with videos related to

Sort By:

Pageof 10

You have reached the last page of results.This site can display upto 93 results.

Ebiomedicine|April 17, 2026

An observational study to test the potency of GLP-grade phenol-free lyophilised leishmanin antigen formulationThalia Pacheco-Fernandez, Laura Klenow, Shin-Ichi Inoue, et al.

Nature Communications|April 2, 2021

Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humansAngelica Gualtieri, Nikolina Kyprianou, Louise C Gregory, et al.

American Journal of Medical Genetics. Part A|December 12, 2019

The sixth international RASopathies symposium: Precision medicine-From promise to practiceKaren W Gripp, Lisa Schill, Lisa Schoyer, et al.

Pageof 10